Black adolescents who lived in poverty and were less optimistic about the future showed accelerated aging in their immune cells and were more likely to have elevated insulin resistance at ages 25-29, researchers have found.
Jul 25, 2022
0
58
In an internationally conducted clinical trial lead by Dana-Farber involving patients with recurrent ovarian cancer that is resistant to platinum therapy, a novel conjugate therapy called mirvetuximab soravtansine resulted ...
Jan 31, 2023
0
73
Radiotherapy, which uses high-energy radiation to kill cancer cells, typically follows a dosing and treatment plan based on clinical research to minimize the impact of the radiation on healthy tissues. However, since the ...
Jan 31, 2023
0
90
Merck & Co. on Thursday won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments.
Sep 4, 2014
0
0
The International Association for the Study of Lung Cancer (IASLC) commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced ...
Nov 16, 2015
0
12
Nuclear research has provided new information about the longevity of kidney stones, one of the most common disorders of the urinary tract, affecting 1 in 10 Australian men and 1 in 35 Australian women during their lifetime.
Oct 2, 2015
0
28
Improving proton therapy for cancer treatment is one of the many advances in accelerator science that have been fast-tracked by a unique approach to academia-industry training, led by the Cockcroft Institute. The two programmes, ...
Apr 21, 2015
0
18
Both the US and UK are pouring money into building proton accelerators to treat cancer. They have been described as the world's "most costly medical devices" but in an article published in the British Medical Journal today, ...
Apr 18, 2012
0
0
When you stand in the 27km-long Large Hadron Collider tunnel deep under Switzerland and France it looks as if the chain of blue magnets simply stretches off to infinity. So when people talk about putting particle accelerators ...
Aug 1, 2013
0
1
Vijoice (alpelisib) has been granted accelerated approval for severe PIK3CA-related overgrowth spectrum (PROS), the U.S. Food and Drug Administration announced April 6.
Apr 19, 2022
0
2
